Herpes simplex virus type 2 and HIV-1: The dialogue between the 2 organisms continues

Journal of Infectious Diseases

Volumn 195, Issue 9, 2007, Pages 1242-1244

  Corey, Lawrence ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EDITORIAL; HAEMOPHILUS DUCREYI; HERPES SIMPLEX VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION RISK; MALE HOMOSEXUAL; PREVALENCE; PRIORITY JOURNAL; TREPONEMA PALLIDUM; VIRUS REACTIVATION;

HERPES SIMPLEX; HERPESVIRUS 2, HUMAN; HIV INFECTIONS; HIV-1; HUMANS; PREVALENCE; WORLD HEALTH;

EID: 34247520467     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/513570     Document Type: Editorial

References (35)

1. Kapiga SH, Sam NE, Bang H, et al. The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. J Infect Dis 2007; 195:1260-9 (in this issue).
2. Cachay ER, Frost SDW, Richman DD, Smith DM, Little SJ. Herpes simplex virus type 2 infection does not influence viral dynamics during early HIV-1 infection. J Infect Dis 2007; 195:1270-7 (in this issue).
3. Corey L, Wald A, Celum C, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immun Defic Syndr 2004; 35:435-45.
4. Stamm W, Handsfield HH, Rompalo A, Ashley R, Roberts P, Corey L. Association of genital ulcer disease with risk of HIV infection in homosexual men. JAMA 1988; 260:1429-33.
5. Holmberg SD, Stewart JA, Gerber AR, et al. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 1988; 259:1048-50.
6. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185:45-52.
7. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20: 73-83.
8. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women: effect of acyclovir treatment. J Clin Invest 1997; 99:1092-7.
9. Wald A, Zeh J, Selke S, Warren T, Ashley R, Corey L. Genital shedding of herpes simplex virus among men. J Infect Dis 2002; 186(Suppl 1):S34-9.
10. Krone MR, Wald A, Tabet SR, Paradise M, Corey L, Celum CL. Herpes simplex virus type 2 shedding in HIV-negative men who have sex with men: frequency, patterns, and risk factors. Clin Infect Dis 2000; 30:261-7.
11. Gupta R, Wald A, Krantz E, et al. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract. J Infect Dis 2004; 190:1374-81.
12. Corey L, Wald A, Patel R, et al. Once daily valacyclovir to reduce the risk of transmission of genital herpes. N Engl J Med 2004; 350: 11-20.
13. Magaret AS, Wald A, Huang ML, Selke S, Corey L. Optimizing PCR positivity criterion for detection of HSV DNA on skin and mucosa. J Clin Microbiol (in press).
14. Wald A, Matson P, Ryncarz A, Corey L. Detection of herpes simplex virus DNA in semen of men with genital HSV-2 infection. Sex Transm Dis 1999; 26:1-3.
15. Koelle DM, Abbo H, Peck A, Ziegweld K, Corey L. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. J Infect Dis 1994; 169:956-61.
16. Cunningham AL, Dwyer DE. The pathogenesis underlying the interaction of HIV and herpes simplex virus after co-infection. J HIV Ther 2004; 9:9-13.
17. Reynolds SJ, Risbud AR, Shepherd ME, et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type I acquisition in India. J Infect Dis 2003; 187:1513-21.
18. Koelle DM, Benedetti J, Langenberg A, Corey L. Asymptomatic reactivation of herpes simplex virus in women after first episode of genital herpes. Ann Intern Med 1992; 116:433-7.
19. Benedetti J, Corey L, Ashley R. Recurrence rates of genital herpes after acquisition of symptomatic first episode infection. Ann Intern Med 1994; 121:847-54.
20. Gray RH, Li X, Wawer MJ, et al. Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda. J Infect Dis 2003; 188: 1492-7.
21. Chen CY, Ballard RC, Beck-Sague CM, et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex Transm Dis 2000; 27:30-1.
22. Beyrer C, Jitwatcharanan K, Natpratan C, et al. Molecular methods for diagnosis of genital ulcer disease in a sexually transmitted disease clinic population in northern Thailand: predominance of herpes simplex virus infection. J Infect Dis 1998; 178:243-6.
23. Weiss H, Buve A, Robinson N, et al. The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. AIDS 2001; 15(Suppl 4): S97-108.
24. Celum C, Levine R, Weaver M, Wald A. Genital herpes and human immunodeficiency virus: double trouble. Bull World Health Organ 2004; 82:447-53.
25. Ramjee G, Williams B, Gouws E, van Dyck E, de Deken B, Abdool Karim SS. The impact of incident and prevalent HSV-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa. J Acquir Immune Defic Syndr 2005; 39:333-9.
26. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis 2005; 191:1403-9.
27. Mark KE, Wald A, Selke S, Olin L, Huang M-L, Corey L. Almost half of genital HSV-2 reactivations last 6 hours or less [abstract 2.44]. In: Program and abstracts of the International Herpesvirus Workshop (Seattle). 2006.
28. Kreiss JK, Coombs R, Plummer F, et al. Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J Infect Dis 1989; 160:380-4.
29. Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1 infected men. JAMA 1998; 280:61-6.
30. Gray RH, Li X, Wawer MJ, et al. Determinants of HIV-1 load in subjects with early and later HIV infections, in a general population cohort of Rakai, Uganda. J Infect Dis 2004; 189: 1209-15.
31. Schacker T, Zeh J, Hu H, Shaughnessy M, Corey L. Changes in plasma HIV-1 RNA associated with HSV reactivation and suppression. J Infect Dis 2002; 186:1718-25.
32. Nagot N, Ouedraogo A, Foulongne V, et al. Reduction of HIV-1 RNA levels with therapy to suppress herpes simplex virus. N Engl J Med 2007; 356:790-9.
33. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946-54.
34. Brenchley JM, Schacker TW, Ruff LE, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 2004; 200:749-59.
35. Brenchly JM, Price DA, Douek DC. HIV disease: fallout from a mucosal catastrophe? Nat Immunol 2006; 7:235-9.